share_log

多家上市公司药品被纳入2024年国家医保药品目录

Multiple listed companies' pharmaceutical products have been included in the 2024 National Medical Insurance Pharmaceutical Catalog.

Breakings ·  Nov 28 16:53

This morning (28th), the National Medical Security Administration held a press conference to introduce the adjustment of the national medical insurance drug list in 2024, and announced the new drug list. This medical insurance directory adds 91 new drugs. As of the time of publication, many listed companies such as wuhan hiteck biological pharma, shenzhen salubris pharmaceuticals, apichope pharmaceutical, humanwell healthcare have announced the inclusion of drugs in the 2024 National Medical Insurance Drug List. The new National Medical Insurance Drug List will be officially implemented starting from January 1, 2025.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment